ANZCTR12623000221651

Analysis of features of eye gaze useful in the diagnosis of Parkinson's disease for people living in rural and remote communities. A comparative study between people with early to mid-stage Parkinson's disease and age-matched healthy volunteers.

A comparative clinical study of features of eye gaze for the diagnosis of Parkinson's disease for people living in rural and remote communities. A comparative study between people with early to mid-stage Parkinson's disease and age-matched healthy volunteers.
RMIT University·Not Applicable·Australian New Zealand Clinical Trials Registry·diagnostic testNot yet recruiting
Study focus
Disease/Condition
Parkinson's disease
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
RMIT University
Location
Australia
Timeline & enrollment
Phase
Not Applicable
Start date
Nov 13, 2023
End date
Nov 20, 2026
Primary outcome

Assessment of pupillary light reflex (hippus) using the commercial eye tracker (GP3-HD, Gazepoint Canada);; Assessment of saccades using the commercial eye tracker (GP3-HD, Gazepoint Canada).

Summary

Eye movement abnormalities including the pupillary light reflex (PLR) and saccades occur in movement disorders including Parkinson’s disease. The purpose of this study is to identify robust features of eye gaze as demonstrated using a commercial eye tracking device that may be used to identify and assess eye movement abnormalities in Parkinson’s disease patients and those at risk of developing Parkinson’s disease. The ultimate aim of this work is to develop an automated diagnostic tool for the diagnosis and assessment of eye gaze abnormalities for people living in rural and remote communities. Patients will be able to record their eye gaze under specified conditions. The recordings will be analysed and eye gaze and analysis sent to a specialist physician. The aim of this study is to ascertain features of the PLR and saccades that are most useful in identifying differences between Parkinson’s disease patients and healthy age-matched controls using a commercially available eye tracker. The hypothesis is that Parkinson’s disease patients will exhibit significantly different eye gaze features compared with healthy age-matched controls.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
Australian New Zealand Clinical Trials Registry
Trial ID
ANZCTR12623000221651
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for ANZCTR12623000221651 through Pure Global AI's free database. This Not Applicable trial is sponsored by RMIT University and is currently Not yet recruiting. The study focuses on Parkinson's disease.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.